Skip to main content

Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

The Original Article was published on 09 March 2018

Retraction Note: Stem Cell Research & Therapy (2018) 9:57 https://doi.org/10.1186/s13287-018-0771-y

The Editors-in-Chief have retracted this article at the authors' request. After publication, the authors found errors in the following figure panels:

  • Fig. 2a: The representative ALP staining images of 15 and 30 μM are both chosen from the 30 μM group

  • Figs. 4d, 5h and 5i: The same β-actin blot is used.

  • Fig. 4e and f: The same β-actin blot is used

  • Fig. 5a: The representative ALP staining images of Azo+si-glp-1r-1 and Azo+si-glp-1r-2 are the same

The authors provided the raw data for validation. However, further checks by the Publisher identified some differences between the raw data and the figures, as well as high similarity between the original gel images for Fig. 5b GLP-1 and 5i Fabp4. The Editors-in-Chief and the authors therefore no longer have confidence in the presented data.

All authors agree to this retraction.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiaorui Cao or Zifan Lu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruan, B., Zhu, Z., Yan, Z. et al. Retraction Note: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway. Stem Cell Res Ther 14, 275 (2023). https://doi.org/10.1186/s13287-023-03513-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13287-023-03513-2